The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Qiu, Dong Mei ^a   Wang, Gui Lan ^a   Chen, Li ^a   Xu, Yu Yin ^a   He, Song ^b   Cao, Xiao Lei ^a   Qin, Jing ^a   Zhou, Jia Ming ^a   Zhang, Yi Xin ^b   E, Qun ^a  

^a NANTONG UNIVERSITY   (China)

^b NANTONG TUMOR HOSPITAL   (China)

Author keywords

Autophagy; Beclin 1; HCC; Microvessels; Prognosis proliferation, Apoptosis

Indexed keywords

BECLIN 1; CD34 ANTIGEN; CYCLINE; NORADRENALIN TRANSPORTER; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN; TUMOR MARKER; APOPTOSIS REGULATORY PROTEIN; BAX PROTEIN, HUMAN; BECN1 PROTEIN, HUMAN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MEMBRANE PROTEIN; NET1 PROTEIN, HUMAN; ONCOPROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOPHAGIC GENE; AUTOPHAGY; BAX GENE; BECLIN 1 GENE; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER INFILTRATION; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURVIVAL; CAPILLARY DENSITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NET 1 GENE; ONCOGENE; OVERALL SURVIVAL; PCNA GENE; PRIMARY TUMOR; PROTEIN FUNCTION; PROTO ONCOGENE; STROMA; SURVIVAL RATE; SURVIVIN GENE; TISSUE DISTRIBUTION; TISSUE MICROARRAY; TUMOR INVASION; CELL PROLIFERATION; CHEMISTRY; KAPLAN MEIER METHOD; LIVER TUMOR; MIDDLE AGED; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; ONCOGENE PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84900318897     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-327     Document Type: Article

References (37)

1. Cancer Incidence, Mortality and Prevalence Worldwide in 2008, Section of Cancer Information, GLOBOCAN 2008, [http://globocan.iarc.fr].
2. Bosch FX, Ribes J, Borràs J. Epidemiology of primary liver cancer. Semin Liver Dis 1999, 19:271-285. 10.1055/s-2007-1007117, 10518307.
3. Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 2000, 191:381-388. 10.1016/S1072-7515(00)00700-6, 11030243.
4. Lin XD, Lin LW. Local injection therapy for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2006, 5:16-21.
5. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004, 127(5 Suppl 1):S35-S50.
6. Wang Q, Tan YX, Ren YB, Dong LW, Xie ZF, Tang L, Cao D, Zhang WP, Hu HP, Wang HY. Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis. BMC Cancer 2011, 11:271. 10.1186/1471-2407-11-271, 3145616, 21702992.
7. Qiu J, Huang P, Liu Q, Hong J, Li B, Lu C, Wang L, Wang J, Yuan Y. Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med 2011, 9:166. 10.1186/1479-5876-9-166, 3192685, 21955323.
8. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000, 290:1717-1721. 2732363, 11099404.
9. Kundu M, Thompson CB. Autophagy: basic principles and relevance to disease. Annu Rev Pathol 2008, 3:427-455. 10.1146/annurev.pathmechdis.2.010506.091842, 18039129.
10. Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S, White E. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 2007, 21:1621-1635. 10.1101/gad.1565707, 1899472, 17606641.
11. Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005, 5:726-734. 10.1038/nrc1692, 16148885.
12. Corcelle EA, Puustinen P, Jäättelä M. Apoptosis and autophagy: Targeting autophagy signalling in cancer cells -'trick or treats'?. FEBS J 2009, 276:6084-6096. 10.1111/j.1742-4658.2009.07332.x, 19788415.
13. Livesey KM, Tang D, Zeh HJ, Lotze MT. Autophagy inhibition in combination cancer treatment. Curr Opin Investig Drugs 2009, 10:1269-1279.
14. Turcotte S, Giaccia AJ. Targeting cancer cells through autophagy for anticancer therapy. Curr Opin Cell Biol 2010, 22:246-251. 10.1016/j.ceb.2009.12.007, 4012537, 20056398.
15. Cheong H, Klionsky DJ. Biochemical methods to monitor autophagy-related processes in yeast. Methods Enzymol 2008, 451:1-26.
16. Eskelinen EL, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta 2009, 1793:664-673. 10.1016/j.bbamcr.2008.07.014, 18706940.
17. Kihara A, Kabeya Y, Ohsumi Y, Yoshimori T. Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep 2001, 2:330-335. 10.1093/embo-reports/kve061, 1083858, 11306555.
18. Sun Q, Fan W, Zhong Q. Regulation of Beclin 1 in autophagy. Autophagy 2009, 5:713-716. 10.4161/auto.5.5.8524, 2789700, 19372752.
19. Wang J. Beclin 1 bridges autophagy, apoptosis and differentiation. Autophagy 2008, 4:947-948.
20. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 2003, 100:15077-15082. 10.1073/pnas.2436255100, 299911, 14657337.
21. Pirtoli L, Cevenini G, Tini P, Vannini M, Oliveri G, Marsili S, Mourmouras V, Rubino G, Miracco C. The prognostic role of Beclin 1 protein expression in high-grade gliomas. Autophagy 2009, 5:930-936. 10.4161/auto.5.7.9227, 19556884.
22. Li BX, Li CY, Peng RQ, Wu XJ, Wang HY, Wan DS, Zhu XF, Zhang XS. The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers. Autophagy 2009, 5:303-306. 10.4161/auto.5.3.7491, 19066461.
23. Shen Y, Li DD, Wang LL, Deng R, Zhu XF. Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. Autophagy 2008, 4:1067-1068.
24. Miracco C, Cosci E, Oliveri G, Luzi P, Pacenti L, Monciatti I, Mannucci S, De Nisi MC, Toscano M, Malagnino V, Falzarano SM, Pirtoli L, Tosi P. Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int J Oncol 2007, 30:429-436.
25. Lomonaco SL, Finniss S, Xiang C, Decarvalho A, Umansky F, Kalkanis SN, Mikkelsen T, Brodie C. The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Int J Cancer 2009, 125:717-722. 10.1002/ijc.24402, 19431142.
26. Pan B, Yi J, Song H. MicroRNA-mediated autophagic signaling networks and cancer chemoresistance. Cancer Biother Radiopharm 2013, 28:573-578. 10.1089/cbr.2012.1460, 23841710.
27. Edinger AL, Thompson CB. Defective autophagy leads to cancer. Cancer Cell 2003, 4:422-424. 10.1016/S1535-6108(03)00306-4, 14706333.
28. Zou M, Lu N, Hu C, Liu W, Sun Y, Wang X, You Q, Gu C, Xi T, Guo Q. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling. Cell Signal 2012, 24:1722-1732. 10.1016/j.cellsig.2012.04.009, 22560876.
29. Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer 2007, 7:961-967. 10.1038/nrc2254, 2866167, 17972889.
30. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676. 10.1038/45257, 10604474.
31. Karantza-Wadsworth V, White E. Role of autophagy in breast cancer. Autophagy 2007, 3:610-613. 2859167, 17786023.
32. Levine B. Cell biology: autophagy and cancer. Nature 2007, 446:745-747. 10.1038/446745a, 17429391.
33. Fujii S, Mitsunaga S, Yamazaki M, Hasebe T, Ishii G, Kojima M, Kinoshita T, Ueno T, Esumi H, Ochiai A. Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci 2008, 99:1813-1819.
34. Ahn CH, Jeong EG, Lee JW, Kim MS, Kim SH, Kim SS, Yoo NJ, Lee SH. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS 2007, 115:1344-1349. 10.1111/j.1600-0463.2007.00858.x, 18184403.
35. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939. 10.1016/j.cell.2005.07.002, 16179260.
36. Nicotra G, Mercalli F, Peracchio C, Castino R, Follo C, Valente G, Isidoro C. Autophagy-active beclin-1 correlates with favourable clinical outcome in non-Hodgkin lymphomas. Mod Pathol 2010, 23:937-950. 10.1038/modpathol.2010.80, 20473282.
37. Chen Y, Lu Y, Lu C, Zhang L. Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression. Pathol Oncol Res 2009, 15:487-493. 10.1007/s12253-008-9143-8, 2791489, 19130303.